HemaSphere (Apr 2022)

P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY

  • E Terpos,
  • I Ntanasis-Stathopoulos,
  • E Kastritis,
  • E Hatjiharissi,
  • E Katodritou,
  • E Eleutherakis-Papaiakovou,
  • E Verrou,
  • M Gavriatopoulou,
  • A Leonidakis,
  • S Delimpasi,
  • P Malandrakis,
  • M-C Kyrtsonis,
  • M Papaioannou,
  • A Symeonidis,
  • MA Dimopoulos

DOI
https://doi.org/10.1097/01.HS9.0000829636.39178.19
Journal volume & issue
Vol. 6
pp. 20 – 20

Abstract

Read online

No abstracts available.